ICO is about to KIDNAP a HUGE established market ICO is about to KIDNAP a HUGE established market with this new research!
DoubleBank Believes the following Scheduled Clinical Trial Reports due this July will prove Explosive concerning the Stock Price of ICO We cannot predict how high ICO stock will travel long term. Although this is a forward looking statement we have every reason to believe stock holders will see nothing but positive results concerning medical trials that have just concluded in Australia on behalf of Ico Therapeutics. The next 2 soon to be seen milestones are a follows:
1. ORAL B material pharmacokinetic data to be released in July
2. Bullous Pemphigoid Disease BP-01 material pharmacokinetic data to be released in July